Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models

Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models

Changes to the composition of the microbiome in neoplasia, is termed oncobiosis, may affect tumor behavior through the changes to the secretion of bacterial metabolites. In this study we show, that ursodeoxycholic acid (UDCA), a bacterial metabolite, has cytostatic properties in pancreatic adenocarc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Patrik Kovács, Szandra Schwarcz, Petra Nyerges, Tímea Ingrid Bíró, Gyula Ujlaki, Péter Bai, Edit Mikó
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	ursodeoxycholic acid bile acid epithelial mesenchymal transition oxidative stress cancer stem cell oxidative phosphorylation
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2024.1487685/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gallstone and treatment with ursodeoxycholic acid İn a dog
by: Mehmet ŞAHAL, et al.

Cholelithiasis in Infants: Risk Factors, Management, and the Role of Ursodeoxycholic Acid
by: Sevim Çakar, et al.
Published: (2024-12-01)

Ursodeoxycholic acid for the treatment of hepatic sarcoid: A pre-post pilot study
by: Ethan Weinberg, et al.
Published: (2024-07-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Pathogenic and therapeutic role of bile acids at reflux-gastritis
by: T. L. Lapina, et al.
Published: (2015-03-01)

The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients
by: I. V. Mayev, et al.
Published: (2013-03-01)

Efficacy of ursodeoxycholic acid in reducing the necessity of cholecystectomy due to pre-existing and subsequently formed gallstones in patients who underwent laparoscopic sleeve gastrectomy
by: Muhammed Taha Demirpolat, et al.
Published: (2025-01-01)

Ursodeoxycholic acid relieves clinical severity of COVID-19 in patients with chronic liver diseases
by: Tiantian Hu, et al.
Published: (2025-02-01)

Cost-effective whole-cell biosynthesis of ursodeoxycholic acid using engineered Escherichia coli with a multienzyme cascade
by: Xue Zhang, et al.
Published: (2025-01-01)

The Role of Duodenogastroesophageal Reflux in the Progression of Gastroesophageal Reflux Disease: From Esophagitis to Adenocarcinoma
by: O. A. Storonova, et al.
Published: (2024-08-01)

An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
by: M. V. Mayevskaya, et al.
Published: (2020-01-01)

Effects of dietary bile acid on the growth performance, intestinal health, blood biochemistry, and antioxidative response of Nile tilapia (Oreochromus niloticus) fed high-fat diets
by: Mahmoud A.O. Dawood, et al.
Published: (2025-03-01)

Ursodeoxycholic acid protects against sepsis-induced acute kidney injury by activating Nrf2/HO-1 and inhibiting NF-κB pathway
by: Yunpeng Lou, et al.
Published: (2025-01-01)

Synergistic effects of ursodeoxycholic acid, and quercetin on liver function and systemic inflammation in non-alcoholic fatty liver disease and atrial fibrillation patients
by: O.B. Teslenko, et al.
Published: (2024-06-01)

MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy
by: Lihua Chen, et al.
Published: (2025-01-01)

Transcriptomic characterization of the functional and morphological development of the rumen wall in weaned lambs fed a diet containing yeast co-cultures of Saccharomyces cerevisiae and Kluyveromyces marxianus
by: Zixuan Xu, et al.
Published: (2025-01-01)

Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
by: Mobina Kouhzad, et al.
Published: (2025-01-01)

Possibilities of correction of lipid-phospholipid disorders in patients with non-alcoholic steatohepatitis against obesity and pathology of the biliary tract.
by: A. Yu. Filippova
Published: (2019-11-01)

Primary biliary cirrhosis: clinical and laboratory criteria of diagnostics and up-to-date treatment
by: L. Yu. Il’chenko, et al.
Published: (2011-09-01)

Integrated metabolomics and proteomics analysis to provide insights into muscle atrophy of turbot Scophthalmus maximus by dietary Clostridium autoethanogenum protein
by: Shihui Pan, et al.
Published: (2025-03-01)

Intestine-derived fibroblast growth factor 19 alleviates lipopolysaccharide-induced liver injury by regulating bile acid homeostasis and directly improving oxidative stress
by: Xiaomeng Tang, et al.
Published: (2025-01-01)

The bile acid chenodeoxycholic acid associates with reduced stroke in humans and mice
by: Vera F. Monteiro-Cardoso, et al.
Published: (2025-01-01)

Genome Mining and Characterization of Two Novel <i>Lacticaseibacillus rhamnosus</i> Probiotic Candidates with Bile Salt Hydrolase Activity
by: Gianluigi Agolino, et al.
Published: (2025-01-01)

The Novel Elemene Derivative, OMe-Ph-Elemene, Attenuates Oxidative Phosphorylation and Facilitates Apoptosis by Inducing Intracellular Reactive Oxygen Species
by: Jianhua Guo, et al.
Published: (2024-12-01)

Different approaches in management of neonatal unconjugated hyperbilirubinemia: a review article
by: Amira A. Fouly, et al.
Published: (2024-11-01)

The Regeneration of Intestinal Stem Cells Is Driven by miR-29-Induced Metabolic Reprogramming
by: Yingying Lin, et al.
Published: (2024-11-01)

COVID-19 in Patients with Primary Biliary Cholangitis
by: М. К. Prashnova, et al.
Published: (2022-09-01)

Protective effect of UDCA against IL-11- induced cardiac fibrosis is mediated by TGR5 signalling
by: B. Reilly-O’Donnell, et al.
Published: (2024-12-01)

Mitochondrial Dysfunction: Effects and Therapeutic Implications in Cerebral Gliomas
by: Gerardo Caruso, et al.
Published: (2024-11-01)

Alterations of bile acid metabolism in patients with functional bowel disorders: a case-control study
by: Serhii Polishchuk, et al.
Published: (2023-11-01)

Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
by: Samantha H. Bai, et al.
Published: (2024-12-01)

The clinical and biochemical effectiveness and safety of cholic acid treatment for bile acid synthesis defects: a systematic review
by: Yasmin Polak, et al.
Published: (2024-12-01)

Gut Bifidobacterium pseudocatenulatum protects against fat deposition by enhancing secondary bile acid biosynthesis
by: Andong Zha, et al.
Published: (2024-12-01)

Dietary bile acids supplementation decreases hepatic fat deposition with the involvement of altered gut microbiota and liver bile acids profile in broiler chickens
by: Minghui Wang, et al.
Published: (2024-08-01)

<i>In Vitro</i> Biodegradability of Phosphorylated Hyaluronic Acid by Testicular Hyaluronidase
by: Elvira A. Khaybrakhmanova, et al.
Published: (2023-11-01)

The Effect of Cord Blood Bile Acid Levels on the Meconium Passage in Utero in Normal Pregnancies
by: Saynur Sarıcı Yılmaz, et al.
Published: (2015-08-01)

Research Progress on the Interaction between Taurine Metabolism and the Gut Microbiota
by: YANG Xinyu, WU Qingjie, MI Shengquan, ZHANG Yanzhen, GUO Junxia
Published: (2025-02-01)

Gut bacteria Prevotellaceae related lithocholic acid metabolism promotes colonic inflammation
by: Liping Chen, et al.
Published: (2025-01-01)

Recent progress in metabolomics for analyzing common infertility conditions that affect ovarian function
by: Hiroshi Kobayashi, et al.
Published: (2024-01-01)

Metabolic plasticity in pancreatic cancer: The mitochondrial connection
by: Noemi Ghiglione, et al.
Published: (2025-02-01)